Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
Completed
Conditions studied: Osteoporosis, Prostate Cancer
In brief
RATIONALE: Measuring bone mineral density may help doctors predict whether prostate cancer will come back. It may also help the study of prostate cancer in the future. PURPOSE: This clinical trial is studying whether bone mineral density affects cancer recurrence in patients with early stage prostate cancer.
Key facts
- Study ID
- NCT00176579
- Run by
- University of Medicine and Dentistry of New Jersey
- People needed
- 27
- Starts
- 2003-06-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2011-08-12
Who can join
Age: 50 and older, up to 75. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.